Medinex Management

Management criteria checks 4/4

Medinex's CEO is Jessie Low, appointed in Jun 2017, has a tenure of 6.92 years. total yearly compensation is SGD325.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 22.32% of the company’s shares, worth SGD5.27M. The average tenure of the management team and the board of directors is 6.5 years and 5.5 years respectively.

Key information

Jessie Low

Chief executive officer

S$325.0k

Total compensation

CEO salary percentage	100.0%
CEO tenure	6.9yrs
CEO ownership	22.3%
Management average tenure	6.5yrs
Board average tenure	5.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jessie Low's remuneration changed compared to Medinex's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2023	n/a	n/a	S$2m
Jun 30 2023	n/a	n/a	S$2m
Mar 31 2023	S$325k	S$325k	S$2m
Dec 31 2022	n/a	n/a	S$2m
Sep 30 2022	n/a	n/a	S$1m
Jun 30 2022	n/a	n/a	S$2m
Mar 31 2022	S$338k	S$338k	S$3m
Dec 31 2021	n/a	n/a	S$3m
Sep 30 2021	n/a	n/a	S$4m
Jun 30 2021	n/a	n/a	S$4m
Mar 31 2021	S$330k	S$324k	S$3m
Sep 30 2020	n/a	n/a	S$3m
Jun 30 2020	n/a	n/a	S$3m
Mar 31 2020	S$354k	S$405k	S$3m

Compensation vs Market: Jessie's total compensation ($USD238.02K) is below average for companies of similar size in the SG market ($USD371.09K).

Compensation vs Earnings: Jessie's compensation has been consistent with company performance over the past year.

CEO

Jessie Low (56 yo)

6.9yrs

Tenure

S$325,000

Compensation

Ms. Mui Choo Low, also known as Jessie, serves as an Executive Director at Medinex Limited since May 17, 2017 and its Chief Executive Officer since June 1, 2017. Ms. Low is responsible for the overall man...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Mui Choo Low	CEO & Executive Director	6.9yrs	S$325.00k	22.32% SGD 5.3m
Siam Kiang Low	Financial Controller	less than a year	no data	0.11% SGD 24.9k
Kim Hung Lee	Chief Operating Officer	6.5yrs	no data	no data
Valerie Low	Chief Business Development Officer	no data	no data	no data
Yee-Hoi Chai	Chief Tax Officer & Joint Company Secretary	no data	no data	1.28% SGD 302.3k
Moi Heyang Lin	Joint Company Secretary	no data	no data	no data

6.5yrs

Average Tenure

Experienced Management: OTX's management team is seasoned and experienced (6.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Mui Choo Low	CEO & Executive Director	7yrs	S$325.00k	22.32% SGD 5.3m
Tai Toon Lim	Lead Independent Non-Executive Director	5.5yrs	S$25.00k	no data
Bin Lin Ye	Independent Non-Executive Director	3.7yrs	S$20.00k	0.019% SGD 4.4k
Lee Meng Tan	Non-Executive Chairman	7yrs	S$20.00k	15.85% SGD 3.7m
Venkata Subramanian	Independent Non-Executive Director	2.8yrs	S$20.00k	no data

5.5yrs

Average Tenure

57yo

Average Age

Experienced Board: OTX's board of directors are considered experienced (5.5 years average tenure).

Medinex Management

Management criteria checks 4/4

Key information

Recent management updates

Medinex Limited Announces Re-Designation of Low Siam Kiang from Chief Integration Officer to Financial Controller

Medinex Limited, Annual General Meeting, Jul 27, 2023

Medinex Limited, Annual General Meeting, Jul 27, 2022

Medinex Limited Announces Redesignation of Low Siam Kiang from Financial Controller to Chief Integration Officer

Medinex Limited Appoints Liew Wei Chun as Chief Financial Officer

Non-Executive Chairman recently bought S$94k worth of stock

Recent updates

Medinex Limited Announces Re-Designation of Low Siam Kiang from Chief Integration Officer to Financial Controller

New minor risk - Earnings quality

Upcoming dividend of S$0.01 per share at 8.0% yield

Medinex Limited Approves Final Dividend for the Year Ended March 31, 2023

Full year 2023 earnings released: EPS: S$0.013 (vs S$0.021 in FY 2022)

Medinex Limited, Annual General Meeting, Jul 27, 2023

Samintharaj Kumar acquired an unknown majority stake in Nuffield Dental Holdings from Medinex Limited (Catalist:OTX) for SGD 1.3 million.

New minor risk - Earnings quality

Full year 2023 earnings released

Medinex Limited Recommends Final Dividend for Fiscal Year Ended 31 March 2023

First half 2023 earnings released: EPS: S$0.005 (vs S$0.016 in 1H 2022)

Medinex Limited Announces Interim Dividend for the Financial Year Ending 31 March 2023, Payable on 18 January 2023

Medinex Limited Approves Final Dividend Tax Exempt One-Tier Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings released: EPS: S$0.021 (vs S$0.027 in FY 2021)

Medinex Limited, Annual General Meeting, Jul 27, 2022

Full year 2022 earnings released

Medinex Limited Announces Redesignation of Low Siam Kiang from Financial Controller to Chief Integration Officer

Medinex Limited Appoints Liew Wei Chun as Chief Financial Officer

Medinex Limited (Catalist:OTX) completed the acquisition of Carlin Management Services Pte. Ltd from Lee Lay Lian.

Non-Executive Chairman recently bought S$94k worth of stock

Independent Non-Executive Director Yiap Fook Wee has left the company

Full year 2021 earnings released: EPS S$0.027 (vs S$0.022 in FY 2020)

Full year 2021 earnings released

Medinex Limited (Catalist:OTX) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

Medinex Limited Announces Retirement of Suresh Kumar as Independent Non-Executive Director, Chairman of the Nominating Committee, and Member of the Audit Committee and Remuneration Committee

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age